Spotlight on Parkinson's disease
Motor disorders are a well-known symptom of Parkinson's disease. But in recent years, research has highlighted that many patients experience greater problems from other, lesser known symptoms, such as anxiety and depression.
Parkinson’s may start in the gut
Researchers at Karolinska Institutet and the University of North Carolina have mapped out the cell types behind various brain disorders. One interesting finding was that cells from the gut's nervous system are involved in Parkinson's disease, indicating that the disease may start there.
Antioxidants in diet linked to lower risk of Parkinson’s disease
People who consume high levels of vitamin C and E in their diet may have a lower risk of Parkinson’s disease than people who get only small amounts of these nutrients, according to a new study from University of Milano-Bicocca, Italy, and Karolinska Institutet. The study was published in Neurology.
New findings about how Parkinson’s disease develops
A new study by researchers at Karolinska Institutet shows that the protein alpha-synuclein, which accumulates in patients with Parkinson’s disease, occurs bound to lipoprotein particles in cerebrospinal fluid, which may explain how the disease spreads in the nervous system. The study is published in the scientific journal PNAS.
Slowing down Parkinson’s disease
Meet professor and senior physician Per Svenningsson and one of his patients, Sara Riggare, who was only 32 years old when she developed Parkinson's. This video was produced in 2020 by the Knut and Alice Wallenberg Foundation.
In-depth knowledge on balance training in Parkinson's disease
A new study in the journal NPJ Parkinson's Disease provides an in-depth picture of balance training as a treatment for Parkinson's. The partly disappointing results suggest that exercise programmes may need to be intensified or personalized to a greater extent.
New knowledge paves the way to transplant of dopamine cells
Researchers at Karolinska Institutet and Lund University have conducted a single cell RNA sequencing study of human pluripotent stem cell-derived grafts in an animal Parkinson’s disease model. This is the first study of its kind, and the results are published in Nature Communications.
Still unknown what triggers Parkinson's disease
The best treatment for Parkinson's disease is still a medicine that goes back 50 years, but otherwise a lot is new in the field.
Latest news from KI on Parkinson's disease
Tailored brain-cells to combat Parkinson's disease
The ERC Advanced Grant is one of Europe’s most prestigious programmes for research financing. The grant has now been awarded to Ernest Arenas to tailor dopamine-producing brain cells for patients with Parkinson’s disease.